leisure time -WSS

leisure time

author：hotspot 2025-09-27 23:54:04 - browse：23

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — A newly approved Alzheimer’s drug made by Eisai and Biogen, called Leqembi, aims to clear out amyloid plaques in patients’ brains. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can receive to detect amyloid plaques in their brains, which will offer physicians more options as they treat patients with a new drug to slow the progression of dementia.

The agency that oversees Medicare had previously restricted coverage to a single scan for patients who participated in clinical studies. Advocates had warned that could cause issues related to a new class of Alzheimer’s drugs designed to clear those plaques.

“We know there is significant interest in the medical community about new treatments that may be effective in slowing the development of Alzheimer’s disease. PET scans are an important part of diagnosis and treatment of Alzheimer’s disease,” Centers for Medicare and Medicaid Administrator Chiquita Brooks-LaSure said in a written statement.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Medical device trials still don't enroll enough women, study finds

focus

Wikipedia

WSS

Pfizer is about to make a big push in cancer. Will investors listen?

Change Healthcare cyberattack shows risk of industry consolidation

The system is set up to fail children with medical complexity

The system is set up to fail children with medical complexity

Curing rare childhood diseases will falter unless Congress steps up

Virtual repurposing can help discover new uses for existing drugs

leisure time

leisure time

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Childhood vaccination ad campaign launches in the U.K.

Malaria cases in Florida and Texas: Here’s what you need to know

Doctor of U.S. President Joe Biden says he is fit for duty

Activists slam private health insurers over coverage restrictions

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

After affirmative action ruling, medical educators look to 'holistic review'

Elisabeth Bik tackles the widespread issue of research misconduct

Hepatitis C has a cure — but many Americans still lack access to it

Statins may not be needed by millions of people, study suggests

entertainment

Cholera vaccine supplies dangerously low, outbreaks surging

Pharma companies must ensure equitable access to obesity drugs

Lilly's Alzheimer's drug donanemab backed by FDA advisers

NEJM study measures Covid brain fog, impact on IQ

CDC advisory group OKs chikungunya vaccine

'Essentially witchcraft:' A former naturopath takes on the field

focus

Wikipedia

hotspot

focus